Studies using optical genome mapping grow 67% at ESHG 2026, showing rising global adoption.

At the 2026 European Society of Human Genetics conference, studies featuring optical genome mapping (OGM) increased by 67% from the previous year, highlighting its expanding global use across 17 countries and multiple continents. OGM was prominently applied in research on rare genetic disorders, cancers, reproductive health, and cardiovascular genomics, often combined with other genetic analysis methods. This growth reflects the technology's value in detecting complex genomic changes that traditional methods may miss, signaling its rising importance in clinical research and diagnostics. Bionano Genomics, the provider of OGM solutions, sees this trend as a step toward advancing cytogenomics and digital pathology.